Markets:

Overview

News

Currencies

International

Treasuries

Braxia Scientific Corp (OP:BRAXF)

0.0001 UNCHANGED

Last Price Updated: 2:38 PM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Braxia Scientific Corp

< Previous 1 2 Next >

New Study Suggests Ketamine Could Work Better Without Additional Antidepressants ↗

September 30, 2021

Braxia Scientific Corp. (CSE:BRAX) (OTC:

Via Benzinga

Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold ↗

August 30, 2021

Contents

Via Benzinga

Braxia Scientific Launches Broad Criteria Trial On Psilocybin For Depression ↗

August 27, 2021

Braxia Scientific Corp. (CSE:BRAX) (OTC:

Via Benzinga

Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected ↗

August 02, 2021

Last week in Psychedelics:

Via Benzinga

Braxia Scientific Leadership Receives Funding From Canadian Government To Study Ketamine Therapy ↗

July 28, 2021

Braxia Scientific Corp (CSE:BRAX) (OTC:

Via Benzinga

Psyched: Cybin And Field Trip Head To Wall Street, AOC Pushes For Federal Psychedelics Research, Off-Label Ketamine Covered By Insurance In Canada ↗

July 26, 2021

Cybin Inc. (NEO: CYBN) (OTCQB:

Via Benzinga

Canadian Insurance Provider To Cover Off-Label Use Of Ketamine For Treating Depression ↗

July 22, 2021

Braxia Scientific Corp. (CSE:BRAX) (OTC:

Via Benzinga

How To Invest In "Magic Mushrooms" (Psychedelics) ↗

July 09, 2021

A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest.

Via Talk Markets

Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies ↗

July 02, 2021

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o...

Via Benzinga

Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform ↗

June 21, 2021

Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq...

Via Benzinga

Topics Artificial Intelligence

Psychedelic Drug Stocks Index -21% In May; Now -25% YTD ↗

May 31, 2021

46 psychedelic drug stocks now trade on the various North American stock exchanges and the 11 with the largest market capitalizations make up the Pure-Play Psychedelic Drug Stocks Index.

Via Talk Markets

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.